Watchlist Price Alert

Ginkgo Bioworks Inc. (DNA)

NYSE: DNA · Real-Time Price · USD

9.40

-0.21 (-2.19%)

At close: Jun 27, 2025, 3:59 PM

9.40

-0.05%

After-hours: Jun 27, 2025, 05:55 PM EDT

Ginkgo Bioworks Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-547.03M	-892.87M	-2.11B	-1.84B	-126.72M	-119.86M
Depreciation & Amortization	63.02M	71.55M	44.42M	29.08M	13.86M	10.76M
Stock-Based Compensation	112.34M	229.88M	1.93B	1.61B	476K	771K
Other Working Capital	n/a	-19.05M	-81.35M	55.43M	-16.57M	13.98M
Other Non-Cash Items	142.69M	266.89M	-69.28M	-20.95M	-1.06M	-1.64M
Deferred Income Tax	-936K	-801K	-14.61M	30.21M	4.13M	54.73M
Change in Working Capital	-89.67M	29.84M	-37.01M	-61.54M	-26.52M	10.58M
Operating Cash Flow	-319.58M	-295.5M	-252.2M	-253.82M	-135.83M	-44.66M
Capital Expenditures	-62.54M	-40.8M	-52.27M	-56.52M	-57.82M	-22.22M
Cash Acquisitions	-5.4M	-38.55M	26.65M	-12.04M	n/a	n/a
Purchase of Investments	n/a	n/a	-3.69M	-5M	n/a	-50.13M
Sales Maturities Of Investments	4.52M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	1.19M	-1.34M	-38.08M	304K	-9.3M	-2.25M
Investing Cash Flow	-62.24M	-80.69M	-67.39M	-73.26M	-67.12M	-74.6M
Debt Repayment	-897K	-1.29M	-1.24M	-1.12M	-748K	198.6M
Common Stock Repurchased	n/a	-23K	n/a	-25M	n/a	-408K
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-922K	-1.43M	-2.73M	1.56B	26K	7K
Financial Cash Flow	-1.74M	-3.22M	95.34M	1.53B	90.32M	410.38M
Net Cash Flow	-383.84M	-380M	-223.35M	1.21B	-112.63M	291.12M
Free Cash Flow	-382.13M	-336.3M	-304.47M	-310.34M	-193.65M	-66.88M